Speciality Generic Injectables

  • October 2019 – Launch of the first generic injectable product in USA.
  • July/August 2019 - First inspection by a regulatory agency in EU of the greenfield manufacturing facility (Shamirpet, India).
  • May 2019 – ANDA approval of the first injectable product by the USFDA.
  • March 2019 – BE Pharmaceuticals Inc. is operational in Cary, North Carolina, USA.
  • December 2018 - First WHO inspection of the greenfield manufacturing facility (Shamirpet, India).
  • November 2018 - First USFDA inspection of the greenfield manufacturing facility (Shamirpet, India).
×

The information on this website is intended for use only by residents of the United States of America. The product information on this site is provided for general information purposes only and is not intended to be a substitute for the actual approved product information. This information is neither medical advice nor a substitute for discussions with a qualified medical professional. The products listed are available only through prescription by a qualified medical professional. BE Pharmaceuticals Inc. and its affiliates shall not be responsible for the reliance on or use of any information contained herein. The reader understands and agrees to the foregoing.

I AgreeI Decline

×

Adverse Event Reporting